Single User License
INR 16680
Site License
INR 33360
Corporate User License
INR 50040

Service Tax Additional

select a format
Price

Single User License
USD 250
Site License
USD 500
Corporate User License
USD 750

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Alimera Sciences, Inc. (ALIM)-Medical Equipment-Deals and Alliances Profile

Alimera Sciences, Inc. (ALIM)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME139593D
  • |
  • Pages: 31
  • |
  • October 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Alimera Sciences, Inc. (Alimera) is a biopharmaceutical company that research, develops and commercializes prescription ophthalmic pharmaceuticals. The company's products include Iluvien, an intravitreal implant of fluocinolone acetonide which is used for the treatment of chronic diabetic macular edema. Its product is designed to treat early- and late-stage diseases such as diabetic macular edema, wet and dry age-related macular degeneration and retinal vein occlusion. The company distributes its products in France, Austria, Portugal, the Czech Republic, Denmark, Finland, Germany, Spain, the UK and others. Alimera is headquartered in Alpharetta, Georgia, the US.

Alimera Sciences, Inc. (ALIM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.,

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Alimera Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Alimera Sciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6

Alimera Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Alimera Sciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 8

Alimera Sciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9

Alimera Sciences, Inc., Medical Equipment, Deal Details 10

Equity Offering 10

Alimera Sciences Completes Private Placement Of Units For US$40 Million 10

Alimera Sciences Files Registration Statement For Public Offering Of US$75 Million 12

Alimera Sciences Completes IPO For US$72 Million 13

Acquisition 15

Alimera Sciences Mulls for Sale 15

Alimera Sciences, Inc.-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

Aug 03, 2016: Alimera Sciences Announces Second Quarter 2016 Financial Results and Provides Business Update 19

Jul 26, 2016: Alimera Sciences Pre-Announces Record Second Quarter 2016 Revenue 21

May 04, 2016: Alimera Sciences Announces First Quarter 2016 Financial Results 22

Mar 02, 2016: Alimera Sciences Reports Record Fourth Quarter and Full Year 2015 Financial Results 24

Nov 05, 2015: Alimera Sciences Reports Third Quarter 2015 Financial Results 26

Aug 10, 2015: Alimera Sciences Reports Second Quarter 2015 Financial Results 28

Product News 30

Mar 19, 2015: Alimera Sciences to Host Analyst and Investor Luncheon on Wednesday, March 25, 2015 in New York City 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31

List of Figures

Alimera Sciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1

Alimera Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1

Alimera Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1

Alimera Sciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1

Alimera Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Alimera Sciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 6

Alimera Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Alimera Sciences, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 8

List of Tables

Alimera Sciences, Inc., Medical Equipment, Key Facts, 2015 1

Alimera Sciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1

Alimera Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 5

Alimera Sciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 6

Alimera Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 7

Alimera Sciences, Inc., Deals By Market, 2010 to YTD 2016 8

Alimera Sciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 9

Alimera Sciences Completes Private Placement Of Units For US$40 Million 10

Alimera Sciences Files Registration Statement For Public Offering Of US$75 Million 12

Alimera Sciences Completes IPO For US$72 Million 13

Alimera Sciences Mulls for Sale 15

Alimera Sciences, Inc., Key Competitors 16

Alimera Sciences, Inc., Key Employees 17

Alimera Sciences, Inc., Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Alimera Sciences, Inc., Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com